Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Engineers Crack DNA Code of Autoimmune Disorders

By Drug Discovery Trends Editor | June 9, 2015

Autoimmune diseases such as lupus and psoriasis are baffling – when the body attacks itself, there appears to be no cure or therapy that can fully stop it.

But scientists say they’ve figured out an “unexpectedly general” set of rules that determine how molecules become prone to patterns of self-destructive behavior, according to a study published this week by a UCLA team in the journal Nature Materials.

In healthy patients, viral DNA triggers an immune response by tripping a receptor called TLR9. But in patients with lupus or psoriasis, their very own “self-DNA” sets off the response.

The scientists at UCLA’s Henry Samueli School of Engineering and Applied Science and California NanoSystems Institute used several techniques to probe what was happening at the molecular level in those patients.

They found that a mix of organic and inorganic molecules were forming the patients’ DNA into a kind of liquid crystal zipper structure that bound to the TLR9 receptors – amplifying the immune response.

Typically, the two autoimmune disorders can only be treated using drugs to suppress or modulate the immune response – and by treating the effects of the immune system’s attack on the body.

The “breakthrough” research at UCLA means hope for treating autoimmune disorders at their root cause – and not just the symptoms, said the scientists.

“Our research has identified a set of rules that tell us what types of molecules or materials can set off this aspect of the immune system,” said Gerard C.L. Wong, a professor bioengineering and chemistry at the school, and the lead author. “This new knowledge will make it easier to design new therapeutic strategies to control immune responses.”

Other studies had laid the groundwork for understanding the complex cause-and-effect of the autoimmune response, including a 2012 study which showed how DNA was binding in peptides in lupus, in the journal Science Translational Medicine. A 2008 study began to show how the TLR9 receptor could be activated by the “DNA sugar backbone.”

Other independent studies, including those by the National Psoriasis Foundation, have been investigating the genetic causes of autoimmune disorders.


Filed Under: Genomics/Proteomics

 

Related Articles Read More >

Spatial biology: Transforming our understanding of cellular environments
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
DNA helix 3D illustration. Mutations under microscope. Decoding genome. Virtual modeling of chemical processes. Hi-tech in medicine
Genomics in 2025: How $500 whole genome sequencing could democratize genomic data
A media release and Scientific Report image of Elizabeth Kellogg. - Camera Settings: ILCE-9M2, 12mm, ISO 1000, 1/80, f/3.2, Fri, 04-19-2024 at 10:10. v.12.01.23
St. Jude pioneers gene editing and structural biology to advance pediatric research
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE